LexDanaLexDanabeta
Inventor

STEPHEN WRIGHT

Inventor
GB

Overview

30→
Patents
2021–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 30 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
B01DSeparation7%
C07BGeneral methods of organic chemistry4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C10LFuels not otherwise provided for4%
Y02CCapture, storage, sequestration or disposal of greenhouse gases [ghg]4%
B01FMixing, e.g. dissolving, emulsifying or dispersing1%
C02FTreatment of water, waste water, sewage, or sludge1%
E03BInstallations or methods for obtaining, collecting, or distributing water1%
PatentTitleYear
12,427,160Use of cannabinoids in the treatment of epilepsy202512,392,115Systems and methods for point of use water modification202512,318,356Use of cannabinoids in the treatment of epilepsy202512,172,122Apparatus and system for swing adsorption processes202412,161,607Combination of cannabinoids in the treatment of leukemia202412,150,927Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders202412,064,398Parenteral formulations202412,064,399Use of cannabinoids in the treatment of epilepsy202411,980,648Compositions including ginsenoside 20(S)-Rg3 and methods of using ginsenoside 20(S)-Rg3 to inhibit alpha herpesvirus202411,963,937Use of cannabinoids in the treatment of epilepsy202411,865,126Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin202411,857,913Apparatus and system for swing adsorption processes202411,774,315Flexible lid seal integrity sensor202311,766,411Use of cannabinoids in the treatment of epilepsy202311,752,111Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders and schizophrenia202311,738,035Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin202311,701,330Use of cannabinoids in the treatment of epilepsy202311,679,087Use of cannabinoids in the treatment of Angelman syndrome202311,633,369Use of cannabinoids in the treatment of epilepsy202311,564,935Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin202311,446,258Use of cannabinoids in the treatment of epilepsy202211,426,362Oral cannabinoid formulations202211,400,055Use of cannabidiol in the treatment of epilepsy202211,357,741Use of cannabinoids in the treatment of epilepsy202211,331,620Apparatus and system for swing adsorption processes202211,326,834Conserving mixed refrigerant in natural gas liquefaction facilities202211,311,498Use of cannabinoids in the treatment of epilepsy202211,229,612Parenteral formulations202211,154,516Use of cannabinoids in the treatment of epilepsy202111,154,517Use of cannabinoids in the treatment of epilepsy2021

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2021–2024Patents assigned to GW RES LTD (15)· patent assignee history
2021–2025Based in GB· patent location history
2022Patents assigned to EXXONMOBIL UPSTREAM RES CO (2)· patent assignee history
2022–2024Based in US· patent location history
2023–2024Patents assigned to COMPASS PATHFINDER LTD (3)· patent assignee history
2024–2025Patents assigned to JAZZ PHARMACEUTICALS RESEARCH UK LTD (5)· patent assignee history
2024Patents assigned to EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GW RES LTD152021–2024
JAZZ PHARMACEUTICALS RESEARCH UK LTD52024–2025
COMPASS PATHFINDER LTD32023–2024
EXXONMOBIL TECHNOLOGY & ENGINEERING COMPANY22024
EXXONMOBIL UPSTREAM RES CO22022
Locations
LocationPatentsSpan
GB242021–2025
US62022–2024